Larvol Delta - EILEAN-THERAPEUTICS-APPROVED-TO-INITIATE-FIRST-PATIENT-TRIAL-WITH-BALAMENIB-ZE630302-A-SELECTIVE-BESTINCLASS-MENIN-INHIBITOR

balamenib (ZE63-0302) - Eilean Therap

https://www.prnewswire.com/news-releases/eilean-therapeutics-approved-to-initiate-first-patient-trial-with-balamenib-ze63-0302-a-selective-best-in-class-menin-inhibitor-302085538.html

Mar 11, 2024

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next